Stock Pick for the next Decade 2021-2030
Laurus Labs, A Small Cap pharmaceutical company principally engaged in offering a broad and integrated portfolio of Active Pharmaceuticals Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry.
The company has several unique products which is likely to provide great business in Post COVID period. Management is very keen on expanding the manufacturing capacity. I personally like the management team which is capable of delivering the promises.
Trading around 345 levels, good price to enter. Buy in small quantities on dips and hold for 5 years.
Disclosure: I am holding this stock.